Tedor Pharma and Cardinal Health Regulatory Sciences have formed a collaboration to deliver integrated regulatory solutions to meet the needs of the evolving manufacturing compliance environment in the biopharmaceutical industry.
Frank Sorce brings 30 years of experience in pharmaceutical sales, marketing and business development having held senior sales leadership positions
Tedor Pharma, Inc. www.tedorpharma.com, a full-service contract development and manufacturing organization (CDMO), today announced that they entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine Ltd.'s triple combination drug product for the short-term treatment of transient insomnia.
Tedor Pharma, a full-service contract development and manufacturing organization (CDMO), has entered into an agreement to provide cGMP contract manufacturing services for Sequential Medicine Ltd.’s triple combination drug product for the short-term treatment of transient insomnia.
TEDOR Pharma, Inc., a full-service, end-to-end, contract development and manufacturing company (CDMO) founded in 2001, today announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures, Inc.
Tedor Pharma Inc Generic Acetaminophen; Butalbital; Caffeine Receives Approvals In US
Tedor Pharma’s Generic Acetaminophen; Butalbital Receives Approval In US
The expansion is the first phase in Tedor’s three near-term capital improvements, which are an ongoing strategic effort to expand production capabilities and invest in facilities for new formulations to broaden its customer portfolio, the company said.